Advanced Medical Equipment
Cepheid Reaffirms FY 2012 Guidance; Lowers FY 2012 EPS Guidance
Cepheid announced that for fiscal 2012, it expects total revenue to be approximately $333 million, Net loss per share in the range of $(0.42)-$(0.40) and non-GAAP net income per share in the range of $0.21-$0.23. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of...
Boston Scientific Corp Issues Q4 2012 Guidance; Revenue Guidance In Line With Analysts' Estimates; Lowers FY 2012 Revenue Guidance; Narrows FY 2012 EPS Guidance
Boston Scientific Corp announced that for fourth quarter of 2012, it expects sales in a range of $1.740 billion to $1.815 billion. The Company estimates earnings on a GAAP basis in a range of $0.06 to $0.09 per share. Adjusted earnings, excluding acquisition- and restructuring-related charges and...
Topspin Medical Inc Appoints New Chief Executive Officer, Mr. Kfir Tamar
Topspin Medical Inc announced that its Board of Directors has appointed a new Chief Executive Officer, Mr. Kfir Tamar, with effect from October 17, 2012.
Markets
- Sectors
- U.S.
- Europe
- Asia
Sector Summary
Energy | -0.33% |
Basic Materials | +0.08% |
Industrials | -0.23% |
Cyclical Goods & Services | -0.19% |
Non-Cyclical Goods & Services | +0.07% |
Financials | -0.11% |
Healthcare | -0.10% |
Technology | +0.79% |
Telecoms | -0.32% |
Utilities | -0.75% |
DOW | 13,345.89 | +2.38 | +0.02% |
S&P; 500 | 1,433.82 | +0.63 | +0.04% |
NASDAQ | 3,016.96 | +11.33 | +0.38% |
TR US Index | 129.43 | +0.02 | +0.02% |
Upcoming Events
No related earnings announcements are currently scheduled within the next 7 days.
Analyst Research
Report Title | Price |
---|---|
Provider: Renaissance Capital
|
$92.00
|
Provider: Renaissance Capital
|
$92.00
|
Provider: Renaissance Capital
|
$92.00
|
Provider: Renaissance Capital
|
$92.00
|
Provider: Renaissance Capital
|
$92.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.